FY2027 EPS Estimates for TSE:BHC Reduced by Analyst

Bausch Health Companies Inc. (TSE:BHC) – Analysts at Zacks Research reduced their FY2027 earnings per share estimates for shares of Bausch Health Companies in a report released on Wednesday, November 19th. Zacks Research analyst Team now anticipates that the company will earn $5.38 per share for the year, down from their previous estimate of $6.08. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.55 per share.

Bausch Health Companies (TSE:BHC) last released its quarterly earnings data on Wednesday, October 29th. The company reported C$0.48 EPS for the quarter. Bausch Health Companies had a negative net margin of 1.88% and a positive return on equity of 15.87%. The firm had revenue of C$2.68 billion during the quarter.

Bausch Health Companies Trading Up 0.8%

Bausch Health Companies stock opened at C$8.52 on Friday. Bausch Health Companies has a 1 year low of C$5.91 and a 1 year high of C$12.20. The firm’s 50-day moving average is C$9.02 and its 200-day moving average is C$8.66. The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19. The company has a market cap of C$3.16 billion, a P/E ratio of 8.78, a PEG ratio of 0.21 and a beta of 0.76.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.